Pancreatic neuroendocrine tumors (PanNETs) can have a variety of behaviors. Some stay slow-growing for years, while others take a sudden, aggressive turn, even when they’re small and seem low-risk. That unpredictability has made it hard for doctors and patients to decide on the best course of action: to monitor or to treat aggressively? A new … Continue reading New ALT Biomarker Enhances Prognostic Accuracy in Pancreatic Neuroendocrine Tumors